Jourdain Isabelle, Lachkar Sylvie, Charbaut Elodie, Gigant Benoit, Knossow Marcel, Sobel André, Curmi Patrick A
Signalisation et Différenciation Cellulaires dans les Systèmes Nerveux et Musculaire, U440 Institut National de la Santé et de la Recherche Médicale/Université Pierre et Marie Curie, Paris, France.
Biochem J. 2004 Mar 15;378(Pt 3):877-88. doi: 10.1042/BJ20031413.
Stathmin is a ubiquitous 17 kDa cytosolic phosphoprotein proposed to play a general role in the integration and relay of intracellular signalling pathways. It is believed to regulate microtubule dynamics by sequestering tubulin in a complex made of two tubulin heterodimers per stathmin molecule (T2S complex). The other proteins of the stathmin family can also bind two tubulin heterodimers through their SLD (stathmin-like domain), but the different tubulin:SLD complexes display varying stabilities. In this study, we analysed the relative influence of three regions of SLDs on the interaction with tubulin and the mechanistic processes that lead to its sequestration. Tubulin-binding properties of fragments and chimaeras of stathmin and RB3(SLD) were studied in vitro by tubulin polymerization, size-exclusion chromatography and surface plasmon resonance assays. Our results show that the N-terminal region of SLDs favours the binding of the first tubulin heterodimer and that the second C-terminal tubulinbinding site confers the specific stability of a given tubulin:SLD complex. Our results highlight the molecular processes by which tubulin co-operatively interacts with the SLDs. This knowledge may contribute to drug development aimed at disturbing microtubules that could be used for the treatment of cancer.
Stathmin是一种普遍存在的17 kDa胞质磷蛋白,被认为在细胞内信号通路的整合和传递中发挥着普遍作用。据信它通过将微管蛋白隔离在由每个Stathmin分子两个微管蛋白异二聚体组成的复合物(T2S复合物)中来调节微管动力学。Stathmin家族的其他蛋白质也可以通过其SLD(Stathmin样结构域)结合两个微管蛋白异二聚体,但不同的微管蛋白:SLD复合物显示出不同的稳定性。在本研究中,我们分析了SLD的三个区域对与微管蛋白相互作用的相对影响以及导致其隔离的机制过程。通过微管蛋白聚合、尺寸排阻色谱和表面等离子体共振分析体外研究了Stathmin和RB3(SLD)的片段和嵌合体的微管蛋白结合特性。我们的结果表明,SLD的N端区域有利于第一个微管蛋白异二聚体的结合,第二个C端微管蛋白结合位点赋予给定微管蛋白:SLD复合物特定的稳定性。我们的结果突出了微管蛋白与SLD协同相互作用的分子过程。这一知识可能有助于开发旨在干扰微管的药物,可用于治疗癌症。